Today is #InternationalNeonatalScreeningDay and the BDFA are proud to be members of the UK NBS Collaborative working towards meaningful change and extension to the UK newborn bloodspot programme. #INSD2022

Launched last year, the aim of this day is to raise awareness about the value of neonatal screening, and encourage collaboration and the sharing of best practices. We will be providing an update from the UK SMA NBS Alliance in the next couple of weeks.

The INSD website explains:

“The aim of the day is to raise awareness about the value of neonatal screening, as well as encourage collaboration and the sharing of best practices to continually improve routine screening and ensure the newest scientific evidence is incorporated. The day is also about celebrating the vision of those who have helped make neonatal screening possible and will, in turn, encourage a new generation of stakeholders to extend its benefits to more children and a wider range of conditions.”

What does neonatal screening mean for patients?

Timely access to diagnosis, treatment and care

To find out more information regarding INSD, go to their website, HERE